The effect of hyper or hypoactive thyroid on the renal toxicity of arsenic trioxide has been studied in rats. It was observed that pre-treatment of rats with thyroxine stimulates arsenic excretion in urine. The anti-thyroid drug n-propylthiouracil (PTU), inhibits the accumulation of arsenic in renal tissue. Both treatments affect the renal pathology. Histopathological lesions are less severe in PTU and arsenic-treated rats in comparison to thyroxine and arsenic-treated rats. Ultrastructural studies support light microscopical observations. An adaptive response was noticed against arsenic in PTU pre-treated rats. We attribute this response to decreased glutathione-S-transferase (GSH) activity and increased GSH synthesis in the kidney. A relationship between thyroidal activity and arsenic toxicity is suggested by present observations.
Allen, T. and Rana, S. V. S.2006: Hepatotoxicity of arsenic trioxide in hyper and hypothyroid rats. Journal of Environmental Biology (in press).
2.
Allen, T., Singhal, R. and Rana, S. V. S.2003: Resistance to oxidative stress in a freshwater fish Channa punctatus after exposure to inorganic arsenic. Biological Trace Element Research98, 63-72.
3.
Aposhian, H. V.1997: Enzymatic methylation of arsenic species and other new approaches to As toxicity. Annual Review of Pharmacology and Toxicology37, 397-419.
4.
ASTDR, 1999: Top 20 hazardous substances. ATDSR/EPA priority list for 1999. http://atdsrl.atdsr.edc.gov:8080/cxcx3.html
5.
Barchowsky, A., Dudek, E. J. and Treadwell, M. D.et al.1996: Arsenic induces oxidative stress and NF-kB activation in cultured aortic endothelial cells. Free Radical Biology and Medicine21, 783-790.
6.
Bates, M. N., Smith, A. H. and Hopenhayn-Rich, C.1992: Arsenic ingestion and internal cancers: a review. American Journal of Epidemiology135, 462-476.
7.
Braunilich, H.1987: Transport of p -aminohippurate in renal cortical slices of rats of different ages following treatment with thyroid hormones. Biomedica Biochemica Acta46, 251-276.
8.
Brown, V.2003: Disrupting a delicate balance. Environmental effect on the thyroid. Environmental Health Perspectives111, 642-649.
9.
Chang, W. C., Chen, S. H. and Wu, H. I.et al.1991: Cytoprotective effect of reduced glutathione in arsenical induced endothelial cell injury. Toxicology69, 101-110.
10.
Cronin, R., Inman, L. and Eche, T.1989: Effect of thyroid hormone on gentamycin accumulation in rat proximal tubule lysosomes. American Journal of Physiology257, 86-91.
11.
EDSTAC, 1998: Endocrine disruptor screening and testing advisory committee. Disrupting addicate balance. Effects on Health Perspectives111, 642-649.
12.
Elliott, W. C., Patchin, D. S. and Jones, D. B.1987: Effect of parathyroid hormone activity on gentamycin nephrotoxi-city. Journal of Laboratory and Clinical Medicine107, 48-54.
13.
Ellman, G. L.1959: Tissue sulfhydryl groups. Archives of Biochemistry82, 70-77.
14.
Fowler, B. A., Woods, J. S. and Schiller, C. M.1977: Ultrastructural and biochemical effects of prolonged oral arsenic exposure on liver mitochondria of rats. Environmental Health Perspectives19, 197-204.
15.
Habig, W. H., Pabst, M. J. and Jakoby, W. B.1974: Glutathione-S-transferase. The first enzymatic step in mercaputric acid formation. Journal of Biological Chemistry249, 7130-7139.
16.
Hirata, M., Tanaka, A. and Hisanaga, A.et al.1990: Effect of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters. Toxicology and Applied Pharmacology106, 469-481.
17.
Kirkvliet, N. I., Steppan, L. B. and Koller, L. I.et al.1980: Immunotoxicology studies of sodium arsenate-effects of exposure on tumor growth and cell mediated tumor immunity. Journal of Environmental Pathology and Toxicology4, 65-79.
18.
Kitchin, K. T.2001: Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicology and Applied Pharmacology172, 249-261.
19.
Levander, O. A.1977: Metabolic interrelationships between arsenic and selenium. Environmental Health Perspectives19, 159-164.
20.
Linscheer, W. G., Raheja, K. L. and Cho, C.et al.1980: Mechanism of the protective effect of propylthiouracil against acetaminophen (tylenol) toxicity in the rat. Gastroenterology78, 100-107.
21.
Liu, J., Kadiiska, M. and Liu, Y.et al.2000: Acute arsenic induced free radicals production and oxidative stress-related gene expression in mice. Toxicologist54, 280-281.
22.
Liu, J., Chen, H. and Miller, D. S.et al.2001: Overexpression of glutathione-S-transferase-II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Molecular Pharmacology60, 302-309.
23.
Nandi, D., Patra, R. C. and Swarup, D.2005: Effect of cysteine, methionine, ascorbic acid and thiamine on arsenic-induced oxidative stress and biochemical alterations in rats. Toxicology211, 26-35.
24.
NRC, 1999: Arsenic in the drinking water, 1-310. National Academy Press.
25.
Orrego, H., Carmicheal, F. J. and Philips, M. J.et al.1976: Protection by propylthiouracil against carbontetrachloride induced liver damage. Gastroenterology71, 921-926.
26.
Pomroy, C., Charbonneau, S. M. and McCullogh, S.et al.1980: Human retention studies with 74As. Toxicology and Applied Pharmacology53, 550-556.
27.
Pott, W. A., Bengamin, S. A. and Yang, R. S. H.2001: Pharmacokinetics, metabolism and carcinogenicity of arsenic. Reviews of Environmental Contamination and Toxicology169, 165-214.
28.
Ramanathan, K., Shila, S. and Kumaran, S.et al.2003: Ascorbic acid and a-tocopherol as potent modulators on arsenic induced toxicity in mitochondria. Journal of Nutritional Biochemistry14, 416-420.
29.
Scott, M. 1938: Unenvied. Third Trans International Goitre Conference, p. 34-34.
30.
Shimizu, M., Hochades, J. F. and Fulmer, B. A.et al.1998: Effect of glutathione depletion and metallothionein gene expression in arsenic induced cytotoxicity and c-myc expression in vitro. Toxicological Sciences45, 204-211.
31.
Simeonova, P. P. and Luster, M. I.2001: Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? Journal of Environmental Pathology and Oncology19, 281-286.
32.
Toro, G. and Ackerman, P. G.1975: Practical clinical chemistry. Little Brown and Company. WHO, 1993: Guidelines for drinking water quality. World Health Organisation.
